Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease.
暂无分享,去创建一个
G. Verleden | G. Joos | F. Vermassen | D. Testelmans | K. Bracke | G. Brusselle | I. Demedts | G. V. Van Pottelberge
[1] A. Bergeron,et al. Characterisation of dendritic cell subsets in lung cancer micro-environments , 2006, European Respiratory Journal.
[2] G. Joos,et al. Cigarette Smoke-Induced Pulmonary Inflammation and Emphysema Are Attenuated in CCR6-Deficient Mice1 , 2006, The Journal of Immunology.
[3] Alan D. Lopez,et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.
[4] K. Rabe,et al. Update in chronic obstructive pulmonary disease 2005. , 2006, American journal of respiratory and critical care medicine.
[5] S. Sethi,et al. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.
[6] G. Joos,et al. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. , 2006, American journal of respiratory cell and molecular biology.
[7] R. Pauwels,et al. Elevated MMP-12 protein levels in induced sputum from patients with COPD , 2005, Thorax.
[8] J. Hogg. Why does airway inflammation persist after the smoking stops? , 2006, Thorax.
[9] R. Pauwels,et al. Matrix Metalloproteinase-12 and Cathepsin D Expression in Pulmonary Macrophages and Dendritic Cells of Cigarette Smoke-Exposed Mice , 2005, International Archives of Allergy and Immunology.
[10] R. Pauwels,et al. Pulmonary dendritic cells. , 2005, American journal of respiratory and critical care medicine.
[11] R. Pauwels,et al. Time course of cigarette smoke-induced pulmonary inflammation in mice , 2005, European Respiratory Journal.
[12] D. Postma,et al. Relation between duration of smoking cessation and bronchial inflammation in COPD , 2005, Thorax.
[13] R. Pauwels,et al. Matrix metalloproteinases in asthma and COPD. , 2005, Current opinion in pharmacology.
[14] R. Pauwels,et al. Identification and characterization of human pulmonary dendritic cells. , 2005, American journal of respiratory cell and molecular biology.
[15] A. Iwasaki,et al. Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.
[16] J. Hogg,et al. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease , 2004, The Lancet.
[17] R. Pauwels,et al. Burden and clinical features of chronic obstructive pulmonary disease (COPD) , 2004, The Lancet.
[18] P. Paré,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[19] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[20] V. Lagente,et al. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease , 2004, Inflammation Research.
[21] H. Hammad,et al. Taking our breath away: dendritic cells in the pathogenesis of asthma , 2003, Nature Reviews Immunology.
[22] R. Pauwels,et al. Chronic obstructive pulmonary disease: molecular and cellularmechanisms , 2003, European Respiratory Journal.
[23] Lung-Chi Chen,et al. Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. , 2003, American journal of respiratory cell and molecular biology.
[24] P. Hogendoorn,et al. Aberrant Chemokine Receptor Expression and Chemokine Production by Langerhans Cells Underlies the Pathogenesis of Langerhans Cell Histiocytosis , 2003, The Journal of experimental medicine.
[25] P. Panina-Bordignon,et al. Chemokines and their receptors in asthma and chronic obstructive pulmonary disease , 2003, Current opinion in pulmonary medicine.
[26] L. Nicod,et al. Superoxide anions induce the maturation of human dendritic cells. , 2003, American journal of respiratory and critical care medicine.
[27] C. Caux,et al. REGULATION OF DENDRITIC CELL RECRUITMENT BY CHEMOKINES , 2002, Transplantation.
[28] Y. Mullen,et al. Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin. , 2002, Transplantation.
[29] Ruslan Medzhitov,et al. Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.
[30] David E. Misek,et al. Profiling Changes in Gene Expression during Differentiation and Maturation of Monocyte-derived Dendritic Cells Using Both Oligonucleotide Microarrays and Proteomics* , 2001, The Journal of Biological Chemistry.
[31] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[32] W. Gong,et al. Expression of CCR6 and CD83 by cytokine-activated human neutrophils. , 2000, Blood.
[33] A. Foussat,et al. Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells. , 2000, Blood.
[34] C. Caux,et al. Macrophage Inflammatory Protein 3α Is Expressed at Inflamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors , 2000, The Journal of experimental medicine.
[35] R. Rabin,et al. CC-Chemokine Receptor 6 Is Expressed on Diverse Memory Subsets of T Cells and Determines Responsiveness to Macrophage Inflammatory Protein 3α , 1999, The Journal of Immunology.
[36] M. Goldman,et al. Oxidative stress up‐regulates IL‐8 and TNF‐α synthesis by human dendritic cells , 1998, European journal of immunology.
[37] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[38] S. Shapiro,et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.
[39] T. Mcclanahan,et al. CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells , 1997, The Journal of experimental medicine.
[40] A. Mantovani,et al. Cloning and Characterization of a Specific Receptor for the Novel CC Chemokine MIP-3α from Lung Dendritic Cells , 1997, The Journal of experimental medicine.
[41] Naiem A. Zeid,et al. Tobacco smoke induced lung granulomas and tumors: Association with pulmonary langerhans cells , 1995, Pathology.
[42] H. Hoogsteden,et al. Distribution and immunophenotype of mononuclear phagocytes and dendritic cells in the human lung. , 1994, American journal of respiratory cell and molecular biology.
[43] T. Ley,et al. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. , 1993, The Journal of biological chemistry.
[44] P. Soler,et al. Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells. , 1989, The American review of respiratory disease.
[45] V. Ferrans,et al. Accumulation of Langerhans' cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. , 1988, The American review of respiratory disease.
[46] M. Kaliner,et al. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura , 1986, The Journal of experimental medicine.
[47] R. Crystal,et al. Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. , 1981, Science.